![]() |
Volumn 11, Issue 12, 2001, Pages 1861-1887
|
Patent status of the therapeutically important G-protein-coupled receptors
a
|
Author keywords
Claims; G protein coupled receptor; Intellectual property; Patent
|
Indexed keywords
AMFEBUTAMONE;
BISOPROLOL FUMARATE PLUS HYDROCHLOROTHIAZIDE;
BUSPIRONE;
CETIRIZINE;
DOXAZOSIN;
FAMOTIDINE;
FENTANYL;
FEXOFENADINE;
G PROTEIN COUPLED RECEPTOR;
GENE PRODUCT;
GUANINE NUCLEOTIDE BINDING PROTEIN;
IPRATROPIUM BROMIDE;
IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE;
LATANOPROST;
LORATADINE;
LOSARTAN POTASSIUM;
METOPROLOL;
MIRTAZAPINE;
MONTELUKAST;
NEFAZODONE;
OLANZAPINE;
ONDANSETRON;
OXYCODONE;
QUETIAPINE;
RISPERIDONE;
SALMETEROL XINAFOATE;
SUMATRIPTAN SUCCINATE;
TAMSULOSIN;
TOLTERODINE;
UNINDEXED DRUG;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG TARGETING;
EXPERIMENT;
GENE TARGETING;
GENOME;
LICENCE;
MEDICAL RESEARCH;
PATENT;
PRACTICE GUIDELINE;
PROTEIN FAMILY;
REVIEW;
SEQUENCE HOMOLOGY;
UNINDEXED SEQUENCE;
UNIVERSITY;
|
EID: 0035213854
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.11.12.1861 Document Type: Review |
Times cited : (26)
|
References (22)
|